HomeCompareADMP vs BTI

ADMP vs BTI: Dividend Comparison 2026

ADMP yields 258.06% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADMP wins by $563.86M in total portfolio value
10 years
ADMP
ADMP
● Live price
258.06%
Share price
$0.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$563.90M
Annual income
$319,983,732.54
Full ADMP calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — ADMP vs BTI

📍 ADMP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADMPBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADMP + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADMP pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADMP
Annual income on $10K today (after 15% tax)
$21,935.48/yr
After 10yr DRIP, annual income (after tax)
$271,986,172.66/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, ADMP beats the other by $271,983,790.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADMP + BTI for your $10,000?

ADMP: 50%BTI: 50%
100% BTI50/50100% ADMP
Portfolio after 10yr
$281.97M
Annual income
$159,993,267.41/yr
Blended yield
56.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

ADMP
Analyst Ratings
3
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
-59.7
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADMP buys
0
BTI buys
0
No recent congressional trades found for ADMP or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADMPBTI
Forward yield258.06%5.40%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$563.90M$37.8K
Annual income after 10y$319,983,732.54$2,802.29
Total dividends collected$538.16M$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: ADMP vs BTI ($10,000, DRIP)

YearADMP PortfolioADMP Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$36,506$25,806.45$11,301$601.08+$25.2KADMP
2$127,109$88,046.91$12,799$706.58+$114.3KADMP
3$422,514$286,507.78$14,527$832.38+$408.0KADMP
4$1,342,148$890,057.94$16,527$982.75+$1.33MADMP
5$4,078,469$2,642,370.06$18,846$1,162.95+$4.06MADMP
6$11,868,198$7,504,236.72$21,545$1,379.49+$11.85MADMP
7$33,107,440$20,408,468.42$24,694$1,640.41+$33.08MADMP
8$88,631,800$53,206,838.59$28,378$1,955.69+$88.60MADMP
9$227,957,353$133,121,327.57$32,702$2,337.79+$227.92MADMP
10$563,898,101$319,983,732.54$37,794$2,802.29+$563.86MADMP

ADMP vs BTI: Complete Analysis 2026

ADMPStock

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.

Full ADMP Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this ADMP vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADMP vs SCHDADMP vs JEPIADMP vs OADMP vs KOADMP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.